» Articles » PMID: 10411041

The National Institutes of Health Chronic Prostatitis Symptom Index: Development and Validation of a New Outcome Measure. Chronic Prostatitis Collaborative Research Network

Overview
Journal J Urol
Publisher Wolters Kluwer
Specialty Urology
Date 1999 Jul 20
PMID 10411041
Citations 260
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Chronic abacterial prostatitis is a syndrome characterized by pelvic pain and voiding symptoms, which is poorly defined, poorly understood, poorly treated and bothersome. Research and clinical efforts to help men with this syndrome have been hampered by the absence of a widely accepted, reliable and valid instrument to measure symptoms and quality of life impact. We developed a psychometrically valid index of symptoms and quality of life impact for men with chronic prostatitis.

Materials And Methods: We conducted a structured literature review of previous work to provide a foundation for the new instrument. We then conducted a series of focus groups comprising chronic prostatitis patients at 4 centers in North America, in which we identified the most important symptoms and effects of the condition. The results were used to create an initial draft of 55 questions that were used for formal cognitive testing on chronic prostatitis patients at the same centers. After expert panel review formal validation testing of a revised 21-item draft was performed in a diverse group of chronic prostatitis patients and 2 control groups of benign prostatic hyperplasia patients and healthy men. Based on this validation study, the index was finalized.

Results: Analysis yielded an index of 9 items that address 3 different aspects of the chronic prostatitis experience. The primary component was pain, which we captured in 4 items focused on location, severity and frequency. Urinary function, another important component of symptoms, was captured in 2 items (1 irritative and 1 obstructive). Quality of life impact was captured with 3 items about the effect of symptoms on daily activities. The 9 items had high test-retest reliability (r = 0.83 to 0.93) and internal consistency (alpha = 0.86 to 0.91). All but the urinary items discriminated well between men with and without chronic prostatitis.

Conclusions: The National Institutes of Health chronic prostatitis symptom index provides a valid outcome measure for men with chronic prostatitis. The index is psychometrically robust, easily self-administered and highly discriminative. It was formally developed and psychometrically validated, and may be useful in clinical practice as well as research protocols.

Citing Articles

The characteristics of brain function alterations in patients with chronic prostatitis/chronic pelvic pain syndrome across varying symptom severities evaluated by NIH-CPSI.

Ge S, Xiang Y, Hua X, Wang Z, Hu Q, Guo Y Front Neurosci. 2025; 19:1511654.

PMID: 40078709 PMC: 11897570. DOI: 10.3389/fnins.2025.1511654.


The "prostate-pelvic syndrome" theory used in patients with type-III prostatitis and its correlation with prostate volume.

Zhang X, Li W, Hao Z, Zhou L, Yang C, Du H BMC Urol. 2025; 25(1):9.

PMID: 39819446 PMC: 11737146. DOI: 10.1186/s12894-025-01689-8.


Relationship of Sex and Diagnosis With Symptoms and Illness Impact in Urologic Chronic Pelvic Pain; A Mapp Network Analysis.

Naliboff B, McWilliams T, Clemens J, Pontari M, Stephens-Shields A, Moldwin R Neurourol Urodyn. 2024; 44(2):400-408.

PMID: 39704257 PMC: 11788956. DOI: 10.1002/nau.25648.


Long-term effects of pelvic floor training in male chronic pelvic pain, correlation between subjective and objective outcomes: a study protocol for a randomised controlled trial.

Hallencreutz Grape H, Nordgren B, Renstrom Koskela L BMJ Open. 2024; 14(11):e087620.

PMID: 39496364 PMC: 11535694. DOI: 10.1136/bmjopen-2024-087620.


Inflammatory Prostatitis Plus IBS-D Subtype and Correlation with Immunomodulating Agent Imbalance in Seminal Plasma: Novel Combined Treatment.

Castiglione R, Bertino G, Vicari B, Rizzotto A, Sidoti G, DAgati P Diseases. 2024; 12(10).

PMID: 39452503 PMC: 11508116. DOI: 10.3390/diseases12100260.